Plasminogen activator system in osteoclasts

Journal of Bone and Mineral Research

Volumn 12, Issue 5, 1997, Pages 761-768

  Yang, J N ^a   Allan, E H ^b   Anderson, G I ^b   Martin, T J ^b   Minkin, Cedric ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; PROTEASE NEXIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CATALYSIS; CELL MIGRATION; DNA SEQUENCE; DNA TEMPLATE; ENZYME ACTIVITY; GENE AMPLIFICATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PROTEIN DEGRADATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROBE; TISSUE REPAIR;

EID: 0030989889     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1997.12.5.761     Document Type: Article

References (41)

1. Lijnen HR, Collen D 1993 Molecular interaction between tissue-type plasminogen activator and plasminogen. Meth Enzymol 223:197-206.
2. Martin TJ, Allan EH, Fukumoto S 1993 The plasminogen activator and inhibitor system in bone remodeling. Growth Reg 3:209-214.
3. Kwaan HC 1992 The plasminogen-plasmin system in malignancy. Cancer Metastasis Rev 11:291-311.
4. Niedbala MJ 1993 Cytokine regulation of endothelial cell extracellular proteolysis. Agents Actions Suppl 42:179-193.
5. Bu G, Warshawsky I, Schwartz AL 1994 Cellular receptors for the plasminogen activators. Blood 83:3427-3436.
6. Puzas JE, Ishibe M 1992 Osteoblast/osteoclast coupling. In: Rifkin BR, Gay CV (eds.) Biology and Physiology of the Osteoclast. CRC Press, Boca Raton, FL, U.S.A., pp. 337-355.
7. Delaisse J-M, Vaes G 1992 Mechanism of mineral solubilization and matrix degradation in osteoclastic bone resorption. In: Rifkin BR, Gay CV (eds.) Biology and Physiology of the Osteoclast. CRC Press, Boca Raton, FL, U.S.A., pp. 289-313.
8. Hamilton JA, Lingelbach SR, Partridge NC, Martin TJ 1984 Stimulation of plasminogen activator in osteoblast-like cells by bone-resorbing hormones. Biochem Biophys Res Commun 122:230-235.
9. Hamilton JA, Lingelbach S, Partridge NC, Martin TJ 1985 Regulation of plasminogen activator production by bone-resorbing hormones in normal and malignant osteoblasts. Endocrinology 116:2186-2191.
10. Hoekman K, Löwik CWGM, Ruit MVD, Bijvoet OLM, Verheijen JH, Papapoulos SE 1991 Regulation of the production of plasminogen activators by bone resorption enhancing and inhibiting factors in three types of osteoblast-like cells. Bone Miner 14:189-204.
11. Grills BL, Gallagher JA, Allan EH, Yumita S, Martin TJ 1990 Identification of plasminogen activator in osteoclasts. J Bone Miner Res 5:499-505.
12. Tong H-S, Sakai DD, Sims SM, Dixon SJ, Yamin M, Goldring SR, Snead ML, Minkin C 1994 Murine osteoclasts and spleen cell polykaryons are distinguished by mRNA phenotyping. J Bone Miner Res 9:577-584.
13. Martin TJ, Ng KW, Partridge NC, Livesey SA 1987 Hormonal influences on bone cells. Meth Enzymol 145:324-336.
14. Sambrook J, Fritsch EF, Maniatis T 1989 Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, U.S.A.
15. Shibutani T, Heersche JNM 1993 Effect of medium pH on osteoclast activity and osteoclast formation in cultures of dispersed rabbit osteoclasts. J Bone Miner Res 8:331-336.
16. 2 or bicarbonate concentrations on the resorptive activity of rat osteoclasts. J Bone Miner Res 9:375-370.
17. Asotra S, Gupta AK, Sodek J, Aubin JA, Heersche JNM 1994 Analysis of carbonic anhydrase II mRNA expression in individual rabbit osteoclasts maintained under "resorbing" and "non-resorbing" conditions. J Bone Miner Res 9:1113-1122.
18. Kristensen P, Eriksen J, Blasi F, Danø K 1991 Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract. J Cell Biol 115:1763-1771.
19. Suh TT, Nerlov C, Danø K, Degen JL 1994 The murine urokinase-type plasminogen activator receptor gene. J Biol Chem 269:25992-25998.
20. Leff SE, Rosenfeld MG 1986 Complex transcriptional units: Diversity in gene expression by alternative RNA processing. Ann Rev Biochem 55:1091-1117.
21. Hodges D, Bernstein SI 1994 Genetic and biochemical analysis of alternative RNA splicing. Ad Genet 31:207-281.
22. Friedman GC, Seeds NW 1994 Tissue plasminogen activator expression in the embryonic nervous system. Dev Brain Res 81:41-49.
23. Pittman RN, DiBenedetto AJ 1995 PC12 cells overexpressing tissue plasminogen activator regenerate neurites to a greater extent and migrate faster than control cells in complex extracellular matrix. J Neurochem 64:566-575.
24. Lalou C, Silve C, Rosato R, Segovia B, Binoux M 1994 Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells. Endocrinology 135:2318-2326.
25. Kirchheimer JC, Wojta J, Christ G, Binder BR 1987 Proliferation of a human epidermal tumor cell line stimulated by urokinase. FASEB J 1:125-128.
26. Rabbani SA, Desjardins J, Bell AW, Banville D, Mazar A, Henkin J, Goltzman D 1990 An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells. Biochem Biophys Res Commun 173:1058-1064.
27. Leloup G, Delaisse J-M, Vaes G 1994 Relationship of the plasminogen activator/plasmin cascade to osteoclast invasion and mineral resorption in explanted fetal metatarsal bones. J Bone Miner Res 9:891-902.
28. Quigley JP, Gold LI, Schwimmer R, Sullivan LM 1987 Limited cleavage of cellular fibronectin by plasminogen activator purified from transformed cells. Proc Natl Acad Sci USA 84:2776-2780.
29. Gold LI, Rostagno A, Frangione B, Passalaris T 1992 Localization of the cleavage sites on fibronectin following digestion by urokinase. J Cell Biochem 50:441-452.
30. Campbell PG, Novak JF, Yanosick TB, McMaster JH 1992 Involvement of the plasmin system in dissociation of the insulin-like growth factor-binding protein complex. Endocrinology 130:1401-1412.
31. Nusrat AR, Chapman HA 1991 An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines. J Clin Invest 87:1091-1097.
32. Waltz DA, Sailor LZ, Chapman HA 1993 Cytokines induce urokinase-dependent adhesion of human myeloid cells: A regulatory role for plasminogen activator inhibitors. J Clin Invest 91:1541-1552.
33. Odekon LE, Sato Y, Rifkin DB 1992 Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity. J Cell Physiol 150:258-263.
34. Del Rosso M, Fibbi G, Dini G, Grappone C, Pucci M, Caldini R, Magnelli L, Fimiani M, Lotti T, Panconesi E 1990 Role of specific membrane receptors in urokinase-dependent migration of human keratinocytes. J Invest Dermatol 94:310-316.
35. Anichini E, Fibbi G, Pucci M, Caldini R, Chevanne M, Del Rosso M 1994 Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor. Exp Cell Res 213:438-448.
36. Gyetko MR, Todd RF, Wilkinson CC, Sitrin RG 1994 The urokinase receptor is required for human monocyte chemotaxis in vitro. J Clin Invest 93:1380-1387.
37. Estreicher A, Mühlhauser J, Carpentier J-L, Orci L, Vassalli J-D 1990 The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J Cell Biol 111:783-792.
38. Gudewicz PW, Gilboa N 1987 Human urokinase-type plasminogen activator stimulates chemotaxis of human neutrophils. Biochem Biophys Res Commun 147:1176-1181.
39. Hanaoka H 1979 The origin of the osteoclast. Clin Orthop Rel Res 145:252-263.
40. Dumler I, Petri T, Schleuning W-D 1994 Induction of c-fos gene expression by urokinase-type plasminogen activator in human ovarian cancer cells. FEBS Lett 343:103-106.
41. Bohuslav J, Horejsi V, Hansmann C, Stockl J, Weidle UH, Majdic O, Bartke I, Knapp W, Stockinger H 1995 Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes. J Expt Med 181:1381-1390.